Carr, B. Et Al. 2021. Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes. ANNALS OF MEDICINE AND SURGERY , vol.66 .

Carr, B., Guerra, V., Donghia, R., & Yilmaz, S., (2021). Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes. ANNALS OF MEDICINE AND SURGERY , vol.66.

Carr, B. Et Al. "Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes," ANNALS OF MEDICINE AND SURGERY , vol.66, 2021

Carr, B. Et Al. "Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes." ANNALS OF MEDICINE AND SURGERY , vol.66, 2021

Carr, B. Et Al. (2021) . "Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes." ANNALS OF MEDICINE AND SURGERY , vol.66.

@article{article, author={B. Carr Et Al. }, title={Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomes}, journal={ANNALS OF MEDICINE AND SURGERY}, year=2021}